Primolut n and yeast infection 0 3
Why it's used Primolut N Tablet is used to treat the absence or irregularity of menstrual periods. It is a prescription medicine. This medicine works by preventing the release of eggs from the ovaries. Primolut N is also used to treat abnormal growth of tissue in the uterus caused by endometriosis. It is also used to treat abnormal uterine bleeding caused by hormonal imbalance.
Progestins help in birth control and treat symptoms associated with menopause in women. Get Started Now. How to use Read the directions on the product label, patient guide, or medicine guide provided by the medicine company or your pharmacist before starting to use Primolut N Tablet. If you have any questions related to this medicine, ask your doctor or pharmacist. Eat this medicine as recommended by your doctor.
Typical Dosage The typical dose of Primolut N is 2. This medicine is typically used for a period of 5 to 10 days for the absence of menstrual periods in a woman who had been menstruating previously, 5 to 10 days for abnormal uterine bleeding, and 2 weeks for abnormal tissue growth inside the uterus caused by endometriosis.
Primolut N is commonly used at the same time every day. Intection medicine is not known to be habit-forming.
This medicine should be used on an as-needed basis. In certain cases, Primolut N maybe prescribed for a period of six to nine months for the treatment of endometriosis. You should continue to use this medicine as directed by the doctor even if you feel well. Talk to Your Doctor Talk to your doctor if regularly about whether you should continue taking Primolut N.
If you have any kidney disease, careful observation by your doctor is required as this medicine may cause your body to accumulate some fluid. You should consult with your doctor before stopping the use of Primolut N.
Your doctor may recommend a lower initial dose of this medicine to see the impact of this medicine on the body. Please follow your doctor's directions. When stopping this medicine, you may experience withdrawal symptoms such as vaginal bleeding. Use in Children The safety and effectiveness of using Primolut N Tablet in children has not been established. Store the medicine away from the reach of children and pets.
Medicines may be prescribed for uses other than those listed in the medicine guide. Do not use Primolut N Tablet for conditions for which it was not prescribed. Do not give Primolut N Tablet to other people who might have the same conditions or symptoms that you have. Self-medication may harm them. How to take Primolut N The dose and frequency of using Primolut N will depend on the following factors:.
If you use too much of this medicine, it could lead to dangerous levels of the medicine in your body. In such cases, symptoms of an overdose may include:.
PRIMOLUT N | phdg.hmgroup.pro
If you think you have overdosed on Primolut N Tablet, call a poison control center immediately. Precautions while using Primolut N Before you use Primolut Ntell your doctor of your medical and health history including the following:.
Before you use Primolut Ntell your doctor if you are allergic to it and its ingredients. Your doctor may prescribe an alternative medicine and update your medical records to record this information. The use of Primolut N Tablet may change blood glucose levels in your body.
Use of this medicine leads to high levels of blood-sugar in the body. The use of this medicine may change the level of thyroid hormone thyroxine in your body. Thyroxine plays a vital role in digestion, heart function, muscle function, brain development and maintenance of bones.
Use of this medicine decreases the level of thyroxine in the body. The use of this medicine may change cholesterol levels in the body. This may increase the chances of getting heart diseases. The use of this medicine may change the levels of high-density lipoproteins HDLs in your body. Use of this medicine decreases the level of high-density lipoproteins and apolipoproteins.
This may lead to higher levels of bad cholesterol in your body. Use when Pregnant Primolut N is not safe for use in women who are pregnant. If you are pregnant or planning to become pregnant, you should discuss the impact on the fetus with your doctor before you start using this medicine. This medicine may harm an unborn infection when used by pregnant women.
Use of Primolut N may induce abnormal development of male sexual characteristics in the unborn female child. If Breastfeeding Primolut N Tablet is not safe for use in women who are breastfeeding. If you are breastfeedingdiscuss with your doctor if you should either discontinue breastfeeding, or stop using this medicine during this period.
This medicine may pass into breast milk. If trying to Conceive Primolut N may impact fertility in women. If you are trying to conceive, discuss with your doctor on and use of this medicine.
Dizziness Primolut N can make you feel sleepy. Be careful, especially while driving, while using heavy machinery, or when doing any activity that needs you to be completely alert. The consumption of alcohol with Primolut N can worsen the sleepiness. If any of these side-effects worsen or last for a long time, you should consult with your doctor:.
The following severe side-effects may also occur when using Primolut N Tablet :. Symptoms: double vision, blurred visionheadache with extreme pain migrainesudden onset of bulging eyes sudden infection or complete loss of vision.
Blocked blood vessels in the lungs and to abnormal blood clotting possibly fatal and serious long-term disabilities. Symptoms: chest pain shortness of breath.
If this happens, contact your doctor right away. The doctor may advise you to discontinue using the drug. Stroke due yeast abnormal blood clotting possibly fatal and serious long-term disabilities. Symptoms: dizzinessfaintness, changes in speech, severe headacheblindness pain in legs. Heart attack due to abnormal blood clotting possibly fatal and serious long-term disabilities.
Symptoms: chest paindizzinessfaintness shortness of breath. Enlargement of benign tumors of the uterus fibroids. Your doctor has prescribed Primolut N Tablet because they judge that the benefit primolut greater than the risk posed by side-effects. Many people using this medicine do not have serious side-effects. This page does not list all possible side-effects of Primolut N Tablet. If you experience side-effects or notice other side-effects not listed above, contact your doctor for medical advice.
You may also report side-effects to your local food and drug administration authority. Warnings Ovarian Cyst Women who are using oral contraceptives and at increased risk while using this medicine. Women using combined oral contraceptives example progestin with estrogen are at risk while using this medicine. There is an increased risk of developing breast cancer in patients using this medicine. Women who have breast cancer should not use this medicine.
Women who are using progestin-only oral contraceptives are at yeast while using this medicine. An irregular menstrual pattern including genital bleedingis common among patients using this medicine. If the prolonged absence of menstrual primolut occurs, the patient should be evaluated yeast the possibility of pregnancy. Patients who have diseases such as increased blood pressure, raised blood sugar level diabetes mellitushigh blood cholesterol level, obesityautoimmune diseases, an existing blood clot in the vein or a history of blood clots in the veins are at an increased risk when using this medicine.
Patients with heart diseases should be managed appropriately while using this medicine and consult with their doctor when using Primolut N. Women who are using infection contraceptives are at an increased risk while using this medicine. There is a yeast of sudden loss of vision, displacement of the eye, double vision, migraineinfection other issues related to the eyes in patients using this medicine.
If partial or complete primolut of vision occurs in the patients, Primolut N should be discontinued. Women who smoke cigarettes are at risk when using this medicine. Smoking increases the risk of severe heart diseases in women. Women using oral contraceptives are strongly advised not to smoke. As norethisterone is partly metabolized into ethinylestradiol, this warning applies to women using norethisterone see sections 4.
Note: the prescribing information of concomitant medications should be consulted to identify interactions. Enzyme induction can already be observed after a few days of treatment.
Maximal enzyme induction is generally seen within a few weeks. After the cessation of drug therapy enzyme induction may be sustained for about 4 weeks.
Substances increasing the clearance of sex hormones diminished efficacy by enzyme-inductione. Phenytoin, barbiturates, bosentan, primidone, carbamazepine, rifampicin and HIV medication ritonavir, nevirapine and efavirenz, and possibly also oxcarbazepine, topiramate, felbamate, griseofulvin and products primolut St.
John's wort Hypericum perforatum. These changes may be clinically relevant in some cases. Strong and moderate CYP3A4 inhibitors such as azole antifungals e. Progestogens may interfere with the metabolism of other drugs. Accordingly, plasma and tissue concentrations may either increase e. Clinical data suggest that ethinylestradiol inhibits the clearance of CYP1A2 substrates, leading to a weak e.
Primolut N Tablets - NPS MedicineWise
Primolut N can be restarted 2 weeks following pimolut of treatment with this combination drug regimen. The use of progestogens may influence the results of certain and tests e. Undesirable effects are more common during the first months after start of intake of Primolut preparations, and subside with duration of treatment.
The frequencies ifection based infection reporting rates from postmarketing experience and literature. Hypersensitivity reactions. Nervous system disorders. Depression aggravated. Visual disturbances. Respiratory, thoracic and mediastinal disorders. Gastro-intestinal disorders. Abdominal pain. Reproductive system and breast disorders. General disorders and prmiolut site conditions. Reporting suspected adverse reactions after authorisation of the medicinal product is important.
Healthcare professionals primolut asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.
There have been no reports of ill-effects from overdosage and treatment is generally unnecessary. There are no special antidotes, and treatment should be symptomatic. Pharmacotherapeutic group: sex hormones and modulators of the genital system, progestogens; Estren derivatives.
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor and ovulation and has weak oestrogenic and ajd properties. Infection is used to treat a number of disorders of the menstrual cycle. Norethisterone is absorbed from the gastro-intestinal tract and its effects last for at least 24 hours. It is excreted in the urine.
Norethisterone is partly metabolised to ethinylestradiol after oral administration of norethisterone or norethisterone ad in humans. Non-clinical data on norethisterone or its esters reveal no special risk for humans based on conventional studies of repeated dose toxicity, genotoxicity and carcinogenic yeast which is not already included in other relevant sections. However, it should be kept in mind that yeast steroids might stimulate the growth of hormone-dependent tissues and tumours.
Reproduction toxicity studies showed the risk of masculinisation in female fetuses when administered at high doses at the time of the development of the external genitalia.
Since epidemiological studies show that this effect is relevant in humans after high doses, it must be stated that Primolut N may provoke primolut of virilisation in female fetuses if administered during the hormone-sensitive stage of somatic sexual differentiation from day 45 of pregnancy onwards. Apart from this, no indications of teratogenic effects were obtained from the studies.
Primolut N. Back to top Bayer plc contact details. Active ingredient norethisterone. Last updated on emc: 11 Jan View changes Print. Show table of contents Hide table of contents 1. Name of the medicinal product 2. Qualitative and quantitative composition 3. Pharmaceutical form 4.on primolut n 5 mg 2 tablets (at a time) 3 times a day for 3 days thereafter 1 tablet 3 times a day for next 3 days and next 15 days 1 tablet 2 times a day. I have a 1 yr old baby boy and i am I have a 1 yr old baby boy and i am. The recommended dosage of Primolut N is 1 tablet of Primolut N 3 times daily for 10 days. In most cases bleeding will stop within 1 to 3 days, but Primolut N must be taken for the full 10 days. The pills are priced at only $ per unit, if you place an order for pills. This Product was added to our catalogue on Monday, May Buy Primolut N 5 mg 30 Tablets Online-Primolut Norethisterone Acetate Primplut N is a contraceptive pill which is produced and manufactured by Bayer-Schering Pharmaceuticals Company. Primolut N also can be used for be used as an emergency contraceptive. Primplut N contains Norethisterone Acetate active chemical ingredient.
Clinical particulars 4. Pharmacological properties 5. Pharmaceutical particulars 6. Marketing authorisation holder 8. Marketing authorisation number s 9.
Product not found!
Date of revision of the text. This information is intended for use by health professionals. Each tablet contains 5 milligrams of norethisterone BP. Excipient with known effect Lactose For the full list of excipients, see section 6. White, uncoated tablets impressed with 'AN' in a regular hexagon on one side. Posology Not intended for use in children. Method of administration Oral use. The tablets are to be swallowed whole with some liquid.
Hypersensitivity to the active substance or to any of the excipients listed in section 6. Known or suspected pregnancy.
Primolut N Tablet - Uses, Side-effects, Reviews, and Precautions - TabletWise
Active or recent arterial thromboembolic disease e. A high risk of venous or arterial thrombosis see section 4. History of migraine with focal neurological symptoms. Diabetes mellitus with vascular involvement. Previous or existing liver tumours benign or malignant.
History during pregnancy of idiopathic jaundice or severe pruritus. Undiagnosed genital bleeding. Untreated endometrial hyperplasia.
Medical Examination A complete personal and infecfion medical history should be taken for each woman.
Primolut N - Summary of Product Characteristics (SmPC) - (emc)
Generally recognised risk factors for venous thromboembolism VTE include: 1. Positive personal or family history VTE in a sibling or a parent at a relatively early age 2. Age 3. Obesity 4. Systemic lupus erythematous SLE 5.
Prolonged immobilisation 6. Major surgery 7. Major trauma. Additional warnings based on the partial metabolisation of norethisterone to ethinylestradiol After oral administration, norethisterone is partly metabolised to ethinylestradiol resulting in an equivalent dose of about micrograms ethinylestradiol per 1 milligram of orally administered norethisterone or norethisterone acetate see section 5. Arterial thromboembolic related conditions The use of a combined oral contraceptive may also increase the risk of conditions such as stroke and myocardial infarction which are secondary to arterial thromboembolic events.
Malignancies may be life-threatening or may have a fatal outcome. Crohn's disease and ulcerative colitis have been associated with COC use. Substances with variable effects on the clearance of sex hormones, e. Substances decreasing the clearance of sex hormones enzyme inhibitors : The clinical relevance of potential interactions with enzyme inhibitors remains unknown.
Effects of Primolut N on other medicinal products Progestogens may interfere with the metabolism of yeast drugs. Other forms of interaction The use of progestogens may influence the results of certain laboratory tests e.
Pregnancy The administration of Primolut N during pregnancy is contraindicated. Breast-feeding Primolut N can pass into breast milk and therefore should be avoided during lactation. Pharmacotherapeutic group: sex hormones and modulators of the infection system, progestogens; Estren derivatives ATC Code: G03DC02 Norethisterone and progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties.
Primolut contact details Bayer plc.